LINCOLNPharmaceuticals
Lincoln Pharmaceuticals Ltd — Balance Sheet
₹564.95
-2.30%
Lincoln Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 2.00 Cr | 2.00 Cr | 2.00 Cr | 2.00 Cr | — |
| Share Issued | 2.00 Cr | 2.00 Cr | 2.00 Cr | 2.00 Cr | — |
| Tangible Book Value | 671.23 Cr | 592.51 Cr | 502.18 Cr | 432.49 Cr | — |
| Invested Capital | 671.67 Cr | 593.90 Cr | 504.47 Cr | 434.92 Cr | — |
| Working Capital | 393.72 Cr | 354.46 Cr | 295.07 Cr | 262.36 Cr | — |
| Net Tangible Assets | 671.23 Cr | 592.51 Cr | 502.18 Cr | 432.49 Cr | — |
| Common Stock Equity | 671.67 Cr | 592.84 Cr | 502.47 Cr | 432.88 Cr | — |
| Total Capitalization | 671.67 Cr | 592.84 Cr | 502.47 Cr | 432.88 Cr | — |
| Total Equity Gross Minority Interest | 671.67 Cr | 592.84 Cr | 502.47 Cr | 432.88 Cr | — |
| Stockholders Equity | 671.67 Cr | 592.84 Cr | 502.47 Cr | 432.88 Cr | — |
| Other Equity Interest | 651.64 Cr | 572.81 Cr | 482.44 Cr | 412.85 Cr | — |
| Capital Stock | 20.03 Cr | 20.03 Cr | 20.03 Cr | 20.03 Cr | — |
| Common Stock | 20.03 Cr | 20.03 Cr | 20.03 Cr | 20.03 Cr | — |
| Total Liabilities Net Minority Interest | 125.34 Cr | 107.45 Cr | 84.95 Cr | 101.48 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 19.12 Cr | 15.18 Cr | 12.80 Cr | 10.99 Cr | — |
| Non Current Deferred Taxes Liabilities | 13.00 Cr | 11.46 Cr | 7.94 Cr | 6.45 Cr | — |
| Long Term Provisions | 0.73 Cr | 0.10 Cr | — | — | — |
| Current Liabilities | 106.22 Cr | 92.28 Cr | 72.15 Cr | 90.49 Cr | — |
| Other Current Liabilities | 5.12 Cr | 2.74 Cr | 2.09 Cr | 1.23 Cr | — |
| Current Provisions | 6.49 Cr | 3.52 Cr | 3.89 Cr | 2.66 Cr | — |
| Payables | 84.95 Cr | 86.28 Cr | 64.56 Cr | 85.67 Cr | — |
| Accounts Payable | 84.95 Cr | 72.44 Cr | 50.87 Cr | 71.67 Cr | — |
| Total Assets | 797.01 Cr | 700.29 Cr | 587.42 Cr | 534.36 Cr | — |
| Total Non Current Assets | 297.07 Cr | 253.55 Cr | 220.21 Cr | 181.51 Cr | — |
| Other Non Current Assets | 3.57 Cr | 1000.00 | 2000.00 | 4.58 Cr | — |
| Investmentin Financial Assets | 1.06 Cr | 35000.00 | 32000.00 | 26000.00 | — |
| Available For Sale Securities | 1.06 Cr | 35000.00 | 32000.00 | 26000.00 | — |
| Goodwill And Other Intangible Assets | 0.44 Cr | 0.33 Cr | 0.29 Cr | 0.38 Cr | — |
| Other Intangible Assets | 0.44 Cr | 0.33 Cr | 0.29 Cr | 0.38 Cr | — |
| Net PPE | 186.00 Cr | 186.55 Cr | 158.48 Cr | 150.63 Cr | — |
| Gross PPE | 186.00 Cr | 242.92 Cr | 204.58 Cr | 189.09 Cr | — |
| Construction In Progress | 4.47 Cr | 7.55 Cr | 8.25 Cr | 19.14 Cr | — |
| Other Properties | 181.53 Cr | 21.81 Cr | 5.37 Cr | 4.21 Cr | — |
| Current Assets | 499.94 Cr | 446.74 Cr | 367.21 Cr | 352.85 Cr | — |
| Other Current Assets | 21.56 Cr | 16.11 Cr | 11.30 Cr | 15.96 Cr | — |
| Inventory | 78.68 Cr | 77.17 Cr | 70.03 Cr | 72.74 Cr | — |
| Other Receivables | 35.30 Cr | 43.69 Cr | 26.15 Cr | 35.63 Cr | — |
| Taxes Receivable | 0.68 Cr | — | — | — | — |
| Accounts Receivable | 166.40 Cr | 161.77 Cr | 136.33 Cr | 115.94 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 197.33 Cr | 152.45 Cr | 113.82 Cr | 115.44 Cr | — |
| Other Short Term Investments | 183.91 Cr | 146.70 Cr | 108.77 Cr | 108.51 Cr | — |
| Cash And Cash Equivalents | 13.41 Cr | 5.75 Cr | 5.05 Cr | 6.93 Cr | — |
| Total Debt | — | 1.07 Cr | 2.00 Cr | 2.04 Cr | 0.52 Cr |
| Retained Earnings | — | 507.46 Cr | 417.66 Cr | 348.26 Cr | 282.41 Cr |
| Additional Paid In Capital | — | 64.62 Cr | 64.62 Cr | 64.62 Cr | 64.62 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 0.10 Cr | 0.14 Cr | — | — |
| Current Deferred Taxes Liabilities | — | 0.07 Cr | 0.88 Cr | 4.28 Cr | 3.16 Cr |
| Current Debt And Capital Lease Obligation | — | 1.07 Cr | 2.00 Cr | 2.04 Cr | 0.38 Cr |
| Current Debt | — | 1.07 Cr | 2.00 Cr | 2.04 Cr | 0.38 Cr |
| Other Payable | — | 13.66 Cr | 13.52 Cr | 9.55 Cr | 9.34 Cr |
| Dividends Payable | — | 0.18 Cr | 0.17 Cr | 0.18 Cr | 0.17 Cr |
| Total Tax Payable | — | 0.07 Cr | 0.88 Cr | 4.28 Cr | 3.16 Cr |
| Non Current Prepaid Assets | — | 0.58 Cr | 1.36 Cr | 1.69 Cr | 3.06 Cr |
| Accumulated Depreciation | — | -56.37 Cr | -46.10 Cr | -38.45 Cr | -30.66 Cr |
| Machinery Furniture Equipment | — | 133.32 Cr | 114.16 Cr | 99.25 Cr | 84.80 Cr |
| Buildings And Improvements | — | 60.22 Cr | 58.07 Cr | 47.86 Cr | 35.79 Cr |
| Land And Improvements | — | 20.02 Cr | 18.74 Cr | 18.63 Cr | 17.26 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.30 Cr | 11.83 Cr | 0.48 Cr | 2.40 Cr |
| Prepaid Assets | — | 11.37 Cr | 9.03 Cr | 12.46 Cr | 18.81 Cr |
| Other Inventories | — | 8.92 Cr | 9.25 Cr | 9.82 Cr | 6.77 Cr |
| Finished Goods | — | 37.57 Cr | 30.97 Cr | 27.19 Cr | 16.81 Cr |
| Work In Process | — | 8.28 Cr | 9.18 Cr | 8.72 Cr | 5.53 Cr |
| Raw Materials | — | 22.40 Cr | 20.63 Cr | 27.02 Cr | 17.51 Cr |
| Allowance For Doubtful Accounts Receivable | — | -2.16 Cr | -1.51 Cr | -1.68 Cr | -1.86 Cr |
| Gross Accounts Receivable | — | 163.92 Cr | 137.84 Cr | 117.63 Cr | 115.21 Cr |
| Cash Financial | — | 5.75 Cr | 5.05 Cr | 6.93 Cr | 11.44 Cr |
| Other Non Current Liabilities | — | — | 1000.00 | 1000.00 | -3000.00 |
| Non Current Deferred Revenue | — | — | 4.72 Cr | 4.54 Cr | 4.29 Cr |
| Hedging Assets Current | — | — | 0.03 Cr | 0.15 Cr | 0.08 Cr |
| Long Term Debt And Capital Lease Obligation | — | — | — | 0.00 | 0.14 Cr |
| Long Term Debt | — | — | — | 0.00 | 0.14 Cr |
| Held To Maturity Securities | — | — | — | 0.00 | 14000.00 |
| Minority Interest | — | — | — | — | 0.41 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | — | — | — | 0.16 Cr |
| Long Term Equity Investment | — | — | — | — | 0.08 Cr |
| Investments In Other Ventures Under Equity Method | — | — | — | — | 26000.00 |
| Investmentsin Subsidiariesat Cost | — | — | — | — | 0.08 Cr |
| Goodwill | — | — | — | — | 9.23 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Lincoln Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.